Lipid therapy: A new whiteboard video for patient education

Abstract

Get full access to this article

View all access options for this article.

References

Statistics Canada. Leading causes of death, total population, by age group. March 2020. Available: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310039401 (accessed Mar. 12, 2020).

Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376(9753):1670-81.

Baigent

Keech

Kearney

, et al; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015;385(9976):1397-405.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371(9607):117-25.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet 2019; 393(10170):407-15.

Anderson

Gregoire

Pearson

, et al. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016;32:1263-82.

Cannon

Blazing

Giugliano

, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387-97.

Turgeon

Tsuyuki

Gyenes

Pearson

. Cardiovascular efficacy and safety of PCSK9 inhibitors: systematic review and meta-analysis including the ODYSSEY OUTCOMES Trial. Can J Cardiol 2018;34(12):1600-5.

10.

Brown

. Canadian data provide window on statin use. CMAJ 2016;188(5):325.

11.

McGinnis

Olson

Magid

, et al. Dyslipidemia: factors related to adherence to statin therapy. Ann Pharmacother 2007;41(11):1805-11.

12.

Wouters

Van Dijk

Geers

HCJ

, et al. Understanding statin non-adherence: knowing which perceptions and experiences matter to different patients. PLoS ONE 2016;11(1):e0146272.

13.

Drexel

Coats

AJS

Spoletini

, et al. An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: barriers to be overcome. Eur Heart J Cardiovacs Pharmacother 2020;6(2):115-21.

14.

ATP

III

. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.

15.

Simons

Levis

Simons

. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996;164:208-11.

16.

Hughes

Walley

. Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling. Clin Pharmacol Ther 2003;74:1-8.

17.

Turgeon

Anderson

Grégoire

Pearson

. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists. Can Pharm J (Ott) 2017;150(4):243-50.

18.

Murero

D’Ancona

Karamanoukian

. Use of the Internet by patients before and after cardiac surgery: telephone survey. J Med Internet Res 2001;3(3):e27.

19.

Leaffer

Gonda

. The Internet: an underutilized tool in patient education. Comput Nurs 2000;18(1):47-52.

20.

McMullan

. Patients using the Internet to obtain health information: how this affects the patient-health professional relationship. Patient Educ Couns 2006;63(1-2):24-8.

21.

Innovation, Science and Economic Development Canada. High-speed access for all: Canada’s connectivity strategy. Available: canada.ca/high-speed-access-for-all (accessed Mar. 6, 2020).

22.

Meppelink

van Weert

Haven

Smit

. The effectiveness of health animations in audiences with different health literacy levels: an experimental study. J Med Internet Res 2015;17(1):e11.

23.

Tri

Albers

Koshman

, et al. Dual antiplatelet therapy: a new whiteboard video for patient education. Can Pharm J (Ott) 2018;151(6):368-71.